Plášek, J.; Lazárová, M.; Dodulík, J.; Šulc, P.; Stejskal, D.; Švagera, Z.; Všianský, F.; Václavík, J.
Secretoneurin as a Novel Biomarker of Cardiovascular Episodes: Are We There Yet? A Narrative Review. J. Clin. Med. 2022, 11, 7191.
https://doi.org/10.3390/jcm11237191
AMA Style
Plášek J, Lazárová M, Dodulík J, Šulc P, Stejskal D, Švagera Z, Všianský F, Václavík J.
Secretoneurin as a Novel Biomarker of Cardiovascular Episodes: Are We There Yet? A Narrative Review. Journal of Clinical Medicine. 2022; 11(23):7191.
https://doi.org/10.3390/jcm11237191
Chicago/Turabian Style
Plášek, Jiří, Marie Lazárová, Jozef Dodulík, Patrik Šulc, David Stejskal, Zdeněk Švagera, František Všianský, and Jan Václavík.
2022. "Secretoneurin as a Novel Biomarker of Cardiovascular Episodes: Are We There Yet? A Narrative Review" Journal of Clinical Medicine 11, no. 23: 7191.
https://doi.org/10.3390/jcm11237191
APA Style
Plášek, J., Lazárová, M., Dodulík, J., Šulc, P., Stejskal, D., Švagera, Z., Všianský, F., & Václavík, J.
(2022). Secretoneurin as a Novel Biomarker of Cardiovascular Episodes: Are We There Yet? A Narrative Review. Journal of Clinical Medicine, 11(23), 7191.
https://doi.org/10.3390/jcm11237191
